Showing results (661-670 of 843) with videos related to

Sort By:
Pageof 85
Cell Host & Microbe|December 11, 2020
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to NeutralizationDrew Weissman, Mohamad-Gabriel Alameh, Thushan de Silva, et al.
Mbio|March 12, 2020
Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV VariantsDavid R Martinez, Joshua J Tu, Amit Kumar, et al.
Science (New York, N.Y.)|June 28, 2003
Medicine. The need for a global HIV vaccine enterpriseRichard D Klausner, Anthony S Fauci, Lawrence Corey, et al.
Journal of Virology|August 19, 2011
Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individualsGeorgia D Tomaras, James M Binley, Elin S Gray, et al.
Journal of AIDS & Clinical Research|November 21, 2015
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive IndividualsJonathan D Fuchs, Pierre-Alexandre Bart, Nicole Frahm, et al.
The Journal of Experimental Medicine|June 3, 2009
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infectionNilu Goonetilleke, Michael K P Liu, Jesus F Salazar-Gonzalez, et al.
Journal of Virology|February 1, 2013
Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1Hua-Xin Liao, Chun-Yen Tsao, S Munir Alam, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Immunity|December 16, 2018
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan BarrierMattia Bonsignori, Eric Scott, Kevin Wiehe, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in miceDavid R Martinez, Alexandra Schaefer, Sophie Gobeil, et al.
Pageof 85